0      0

Masterplanning the Future

Feb 1, 2022 2:30pm ‐ Feb 1, 2022 3:00pm

Credits: None available.


A comprehensive outlook on some of the most relevant Pharmaceutical developments in the world that are configuring a new understanding on the role of master plans. In a time of faster project delivery, evolution of process modalities, products and production processes, growing demands for more flexible processes and facilities and a shift in company objectives, the traditional modernist planning model might be transitioning to a new stage and this is the hypothesis and starting point of the presentation. We will look at the following key areas that affects how we plan and arrange our site masterplans for clients: modular design solutions; flexibility; adaptable modules; the drivers for pre-investments to assist speed to market; impact of the various modalities on support functions and designing for adaptability; impact of robotics and the integration of cobots; digitization and next generation technological developments; designing a sustainable future; well building design and creating great working environment. Our new generation of masterplanning methodology is testing renewed strategies to understand and plan sites, and by also using the intersection of the digital and physical, to display information and communicate within client organizations to help plan their futures.


  • Jessica Hays, Project Manager, Strategic Projects, Bayer
  • Jordaan Kemp, Director of Architecture and Process Architect SME, PM Group


Credits: None available.

You must be logged in and own this session in order to post comments.